NDAT Targets PI3K-Mediated PD-L1 Upregulation to Reduce Proliferation in Gefitinib-Resistant Colorectal Cancer

The property of drug-resistance may attenuate clinical therapy in cancer cells, such as chemoresistance to gefitinib in colon cancer cells. In previous studies, overexpression of PD-L1 causes proliferation and metastasis in cancer cells; therefore, the PD-L1 pathway allows tumor cells to exert an ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Tung-Yung, Chang, Tung-Cheng, Chin, Yu-Tang, Pan, Yi-Shin, Chang, Wong-Jin, Liu, Feng-Cheng, Hastuti, Ema Dwi, Chiu, Shih-Jiuan, Wang, Shwu-Huey, Changou, Chun A., Li, Zi-Lin, Chen, Yi-Ru, Chu, Hung-Ru, Shih, Ya-Jung, Cheng, R. Holland, Wu, Alexander, Lin, Hung-Yun, Wang, Kuan, Whang-Peng, Jacqueline, Mousa, Shaker A, Davis, Paul J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464180/
https://www.ncbi.nlm.nih.gov/pubmed/32756527
http://dx.doi.org/10.3390/cells9081830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464180/
https://www.ncbi.nlm.nih.gov/pubmed/32756527
http://dx.doi.org/10.3390/cells9081830

Ejemplares similares